GlassScriptPhysician profile
Anie G Perard
NPI 1659347334
$1,433.00
in general payments reported to CMS, 2019-2025
27 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $106 · 2021: $131 · 2022: $108 · 2023: $405 · 2024: $333 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.39 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $187.81 | 2019-2024 | |
| Astellas Pharma US INC | $171.70 | 2019-2025 | Veozah, Myrbetriq |
| Organon LLC | $130.30 | 2021-2025 | Nexplanon |
| Exact Sciences Corporation | $119.35 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $109.20 | 2019-2022 | |
| Daiichi Sankyo INC. | $81.38 | 2019-2023 | Injectafer |
| Sage Therapeutics, LLC | $67.36 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $61.54 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.00 | 2019-2025 | |
| Myriad Women'S Health, INC. | $54.87 | 2023 | Myrisk |
| Amgen INC. | $47.99 | 2022-2024 | Evenity, Prolia |
| Minerva Surgical, INC | $47.19 | 2024 | |
| Exeltis, USA INC. | $36.67 | 2024-2025 | Slynd |
| Urovant Sciences INC | $26.94 | 2021 | |
| Kci USA, INC. | $25.04 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $24.57 | 2019 | |
| Medtronic, INC. | $22.20 | 2022 | |
| Novo Nordisk INC | $22.02 | 2023 | Wegovy |
| Convatec INC. | $21.98 | 2023 | |
| Kedrion Biopharma, INC. | $18.81 | 2023 | Kedrab, Gammaked, Koate |
| Radius Health, INC. | $17.52 | 2023 | Tymlos |
| Amag Pharmaceuticals, INC. | $17.06 | 2019 | |
| Hologic Sales and Service, LLC | $14.83 | 2024 | Myosure Tissue Removal Device |
| Coopersurgical, INC. | $14.15 | 2022 | |
| Agile Therapeutics, INC. | $13.13 | 2022 | |
| Davol INC. | $12.48 | 2021 | |
| Ethicon US, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anie Perard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.